Copyright Reports & Markets. All rights reserved.

Global Injectable Cytotoxic Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Injectable Cytotoxic Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Alkaloids
    • 1.3.3 Metabolites
    • 1.3.4 Antibiotics
    • 1.3.5 Alkylating agents
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Injectable Cytotoxic Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Tumours
    • 1.4.3 Rheumatoid Arthritis
    • 1.4.4 Multiple Sclerosis
    • 1.4.5 Other
  • 1.5 Global Injectable Cytotoxic Drugs Market Size & Forecast
    • 1.5.1 Global Injectable Cytotoxic Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Injectable Cytotoxic Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Injectable Cytotoxic Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Johnson and Johnson Services
    • 2.1.1 Johnson and Johnson Services Details
    • 2.1.2 Johnson and Johnson Services Major Business
    • 2.1.3 Johnson and Johnson Services Injectable Cytotoxic Drugs Product and Services
    • 2.1.4 Johnson and Johnson Services Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Johnson and Johnson Services Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Injectable Cytotoxic Drugs Product and Services
    • 2.2.4 Sanofi Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 Eli Lilly and Company
    • 2.3.1 Eli Lilly and Company Details
    • 2.3.2 Eli Lilly and Company Major Business
    • 2.3.3 Eli Lilly and Company Injectable Cytotoxic Drugs Product and Services
    • 2.3.4 Eli Lilly and Company Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eli Lilly and Company Recent Developments/Updates
  • 2.4 Bristol-Myers Squibb
    • 2.4.1 Bristol-Myers Squibb Details
    • 2.4.2 Bristol-Myers Squibb Major Business
    • 2.4.3 Bristol-Myers Squibb Injectable Cytotoxic Drugs Product and Services
    • 2.4.4 Bristol-Myers Squibb Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Injectable Cytotoxic Drugs Product and Services
    • 2.5.4 Roche Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Roche Recent Developments/Updates
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Injectable Cytotoxic Drugs Product and Services
    • 2.6.4 Novartis Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novartis Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Injectable Cytotoxic Drugs Product and Services
    • 2.7.4 Pfizer Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Merck KGaA
    • 2.8.1 Merck KGaA Details
    • 2.8.2 Merck KGaA Major Business
    • 2.8.3 Merck KGaA Injectable Cytotoxic Drugs Product and Services
    • 2.8.4 Merck KGaA Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Merck KGaA Recent Developments/Updates
  • 2.9 Amgen
    • 2.9.1 Amgen Details
    • 2.9.2 Amgen Major Business
    • 2.9.3 Amgen Injectable Cytotoxic Drugs Product and Services
    • 2.9.4 Amgen Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Amgen Recent Developments/Updates
  • 2.10 AbbVie
    • 2.10.1 AbbVie Details
    • 2.10.2 AbbVie Major Business
    • 2.10.3 AbbVie Injectable Cytotoxic Drugs Product and Services
    • 2.10.4 AbbVie Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 AbbVie Recent Developments/Updates
  • 2.11 Sun Pharmaceutical
    • 2.11.1 Sun Pharmaceutical Details
    • 2.11.2 Sun Pharmaceutical Major Business
    • 2.11.3 Sun Pharmaceutical Injectable Cytotoxic Drugs Product and Services
    • 2.11.4 Sun Pharmaceutical Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.12 Kelix Bio
    • 2.12.1 Kelix Bio Details
    • 2.12.2 Kelix Bio Major Business
    • 2.12.3 Kelix Bio Injectable Cytotoxic Drugs Product and Services
    • 2.12.4 Kelix Bio Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Kelix Bio Recent Developments/Updates
  • 2.13 Accord Healthcare
    • 2.13.1 Accord Healthcare Details
    • 2.13.2 Accord Healthcare Major Business
    • 2.13.3 Accord Healthcare Injectable Cytotoxic Drugs Product and Services
    • 2.13.4 Accord Healthcare Injectable Cytotoxic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Accord Healthcare Recent Developments/Updates

3 Competitive Environment: Injectable Cytotoxic Drugs by Manufacturer

  • 3.1 Global Injectable Cytotoxic Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Injectable Cytotoxic Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Injectable Cytotoxic Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Injectable Cytotoxic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Injectable Cytotoxic Drugs Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Injectable Cytotoxic Drugs Manufacturer Market Share in 2023
  • 3.5 Injectable Cytotoxic Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Injectable Cytotoxic Drugs Market: Region Footprint
    • 3.5.2 Injectable Cytotoxic Drugs Market: Company Product Type Footprint
    • 3.5.3 Injectable Cytotoxic Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Injectable Cytotoxic Drugs Market Size by Region
    • 4.1.1 Global Injectable Cytotoxic Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Injectable Cytotoxic Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Injectable Cytotoxic Drugs Average Price by Region (2019-2030)
  • 4.2 North America Injectable Cytotoxic Drugs Consumption Value (2019-2030)
  • 4.3 Europe Injectable Cytotoxic Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Injectable Cytotoxic Drugs Consumption Value (2019-2030)
  • 4.5 South America Injectable Cytotoxic Drugs Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Injectable Cytotoxic Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Injectable Cytotoxic Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Injectable Cytotoxic Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Injectable Cytotoxic Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Injectable Cytotoxic Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Injectable Cytotoxic Drugs Market Size by Country
    • 7.3.1 North America Injectable Cytotoxic Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Injectable Cytotoxic Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Injectable Cytotoxic Drugs Market Size by Country
    • 8.3.1 Europe Injectable Cytotoxic Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Injectable Cytotoxic Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Injectable Cytotoxic Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Injectable Cytotoxic Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Injectable Cytotoxic Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Injectable Cytotoxic Drugs Market Size by Country
    • 10.3.1 South America Injectable Cytotoxic Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Injectable Cytotoxic Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Injectable Cytotoxic Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Injectable Cytotoxic Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Injectable Cytotoxic Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Injectable Cytotoxic Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Injectable Cytotoxic Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Injectable Cytotoxic Drugs Market Drivers
  • 12.2 Injectable Cytotoxic Drugs Market Restraints
  • 12.3 Injectable Cytotoxic Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Injectable Cytotoxic Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Injectable Cytotoxic Drugs
  • 13.3 Injectable Cytotoxic Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Injectable Cytotoxic Drugs Typical Distributors
  • 14.3 Injectable Cytotoxic Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Injectable cytotoxic drugs, also known as chemotherapeutic drugs, are medications that treat cancer by targeting rapidly dividing cancer cells and inhibiting their growth and spread. These drugs are administered intravenously (IV), intramuscularly (IM), or subcutaneously (SC) and are often used in combination with other cancer treatments (e.g., surgery, radiation therapy, and targeted therapies) to achieve optimal results. Injectable cytotoxic drugs play a crucial role in the treatment of various cancers, including solid tumours and haematological malignancies.
    According to our (Global Info Research) latest study, the global Injectable Cytotoxic Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Injectable Cytotoxic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Injectable Cytotoxic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Injectable Cytotoxic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Injectable Cytotoxic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Injectable Cytotoxic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Injectable Cytotoxic Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Injectable Cytotoxic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson Services, Sanofi, Eli Lilly and Company, Bristol-Myers Squibb, Roche, Novartis, Pfizer, Merck KGaA, Amgen, AbbVie, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Injectable Cytotoxic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Alkaloids
    Metabolites
    Antibiotics
    Alkylating agents
    Others
    Market segment by Application
    Tumours
    Rheumatoid Arthritis
    Multiple Sclerosis
    Other
    Major players covered
    Johnson and Johnson Services
    Sanofi
    Eli Lilly and Company
    Bristol-Myers Squibb
    Roche
    Novartis
    Pfizer
    Merck KGaA
    Amgen
    AbbVie
    Sun Pharmaceutical
    Kelix Bio
    Accord Healthcare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Injectable Cytotoxic Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Injectable Cytotoxic Drugs, with price, sales quantity, revenue, and global market share of Injectable Cytotoxic Drugs from 2019 to 2024.
    Chapter 3, the Injectable Cytotoxic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Injectable Cytotoxic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Injectable Cytotoxic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable Cytotoxic Drugs.
    Chapter 14 and 15, to describe Injectable Cytotoxic Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now